Germany · 
Who invested in Caprotec Bioanalytics?
Caprotec Bioanalytics's investors include KfW, Creathor Ventures and IBB Beteiligungsgesellschaft.
2008200920102011
$8.8MVenture$5.1MSeries B$2.1MSeries BGermany · Series B startup
Who invested in Caprotec Bioanalytics
3 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$16Mraised across 3 rounds since 2008, from 3 sources
$8.8MVenture$5.1MSeries B$2.1MSeries B
- Latest round
- Series B, $2.1MMay 2011
- Biggest round
- $8.8MVenture · Jan 2008
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $8.8M Jan 2008
- Biggest round
- $8.8M Venture · Jan 2008
- Usual gap between rounds
- 2.3 years the median of 2
The rounds
- May 2011
- May 2010
- Jan 2008
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Caprotec Bioanalytics
How much has Caprotec Bioanalytics raised?
Caprotec Bioanalytics has raised $16M across 3 rounds since 2008.
When did Caprotec Bioanalytics last raise?
Caprotec Bioanalytics's most recent round was a Series B of $2.1M in May 2011.
What was Caprotec Bioanalytics's biggest round?
Caprotec Bioanalytics's largest round on record is $8.8M (Venture), in Jan 2008.
Who backed Caprotec Bioanalytics first?
Caprotec Bioanalytics's first round on record, in Jan 2008, was backed by KfW, Creathor Ventures and IBB Beteiligungsgesellschaft.
What stage is Caprotec Bioanalytics at?
Caprotec Bioanalytics's latest named round is a Series B, in May 2011.
Where is Caprotec Bioanalytics based?
Caprotec Bioanalytics is based in Germany.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.